Rare blood diseases at LLM 2021

Sangmin Lee, MD, Weill Cornell Medicine, New York, NY, shares key highlights that will be addressed in the rare disease session at the Lymphoma, Leukemia & Myeloma Congress 2021. Dr Lee highlights the latest therapies in development for multiple rare blood diseases including paroxysmal nocturnal hemoglobinuria (PNH), systemic mastocytosis, and large granular lymphocytic (LGL) leukemia. This interview took place at the Lymphoma, Leukemia & Myeloma Congress 2021.